Alzheimer
Showing 5076 - 5088 of 5,088
Down's Syndrome, Dementia, Learning Disabilities Trial in Morpeth, Birmingham (Memantine Hydrochloride)
Unknown status
- Down's Syndrome
- +2 more
- Memantine Hydrochloride
-
Morpeth, Northumberland, United Kingdom
- +1 more
Feb 17, 2006
Cognitive Decline Trial in Wuhan (cognitive function)
Unknown status
- Cognitive Decline
- cognitive function
-
Wuhan, Hubei, ChinaDepartment of Anesthesiology, Union Hospital
Feb 27, 2006
Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
Completed
- Cognitive Decline
-
Pittsburgh, Pennsylvania
- +1 more
Oct 31, 2005
Hemispheric Lateralisation of Language Depending of Gender and
Unknown status
- Aging
-
Tours, FranceUniversity Hospital
Oct 14, 2005
Stroke, Aphasia Trial in Malaga (Donepezil)
Completed
- Stroke
- Aphasia
-
Malaga, SpainGabinete Berthier y Martínez, Malaga, Spain. Centro de Investiga
Sep 12, 2005
Aphasia, Stroke Trial in Malaga (memantine, constraint-induced language therapy)
Unknown status
- Aphasia
- Stroke
- memantine
- constraint-induced language therapy
-
Malaga, SpainGabinete Berthier y Martínez and Centro de Investigaciones Médic
Sep 12, 2005
Tardive Dyskinesia Trial in Philadelphia (Galantamine)
Completed
- Tardive Dyskinesia
-
Philadelphia, PennsylvaniaPhiladelphia VA Medical Center
Sep 9, 2005
Peripheral Nervous System Diseases, Chemo-Induced Peripheral Neuropathy Trial in United States (leteprinim potassium
Completed
- Peripheral Nervous System Diseases
- Chemotherapy-Induced Peripheral Neuropathy
- leteprinim potassium (Neotrofin)
-
Berkeley, California
- +5 more
Jun 23, 2005
Stroke, Neurologic Diseases, General Trial in United States (NC-758 (Anti amyloidotic [Aß] agent))
Completed
- Stroke
- Neurologic Diseases, General
- NC-758 (Anti amyloidotic [Aß] agent)
-
Lexington, Kentucky
- +4 more
Jun 23, 2005